Wireless subretinal prostheses allows blind mice to see light

June 19, 2013 by Bob Yirka report
Photovoltaic array with 70 µm pixels placed on top of the retinal pigmented epithelium in the eye. Color insert: fundus photo of a rat eye with subretinally implanted photovoltaic array with 140 µm pixels. Credit:Palanker Lab, Stanford University, CA

(Medical Xpress)—A team of researchers from the U.S. and Scotland has developed a new type of retinal prostheses designed to restore sight to blind patients. In their paper published in the journal Nature Communications, the team describes how they developed a device that can be placed below the surface of the retina to send signals directly to neurons behind damaged photoreceptor cells.

Artificial retinal implants have been in the news a lot lately—as minituration of microelectronics has improved, so too have the devices that have been developed to help restore vision to people who lose their site due to damage to the retina. Diseases such as retinitis pigmentosa in young patients and macular degeneration in those that are older cause damage to the photoreceptors that convert light to signals the neurons beneath them can understand. In this new effort, instead of placing a device over the top of the retina, the researchers placed it under the damaged photoreceptors of test mice and connected it directly to the neurons that lay underneath, providing a direct connection to the brain.

To make use of the implant, goggles are placed on the face with a camera set in the nosepiece. Data from the camera is sent to a tiny computer that in turn sends a signal to a wireless infrared also mounted on the goggles. The laser shines constantly on the (through the photoreceptor layer) which responds by sending directly to the brain via neurons. The entire system is wireless, making it easier to use than other implant systems. The implant itself is also smaller than that used in other devices—approximately half as thick as a human hair—which the researchers say, makes it less susceptible to complications. It's also scalable, meaning that as technology improves more pixels can be added to fine tune the image that is sent to the brain.

Photovoltaic array with 140 µm pixels implanted under the retina in a rat eye. Credit: Palanker Lab, Stanford University, CA

To test their system, the researchers monitored while the implant system was operating. They report that exposure to light caused activity in the visual cortex very similar to what occurs in the brains of mice with undamaged retinas. This they say indicates that the mice are able to see some amount of light, though it's still unclear if they are able to make out patterns.

Explore further: Eye implants make vision-restoring progress

More information: Cortical responses elicited by photovoltaic subretinal prostheses exhibit similarities to visually evoked potentials, Nature Communications 4, Article number: 1980 doi:10.1038/ncomms2980

We have previously developed a wireless photovoltaic retinal prosthesis, in which camera-captured images are projected onto the retina using pulsed near-IR light. Each pixel in the subretinal implant directly converts pulsed light into local electric current to stimulate the nearby inner retinal neurons. Here we report that implants having pixel sizes of 280, 140 and 70 μm implanted in the subretinal space in rats with normal and degenerate retina elicit robust cortical responses upon stimulation with pulsed near-IR light. Implant-induced eVEP has shorter latency than visible light-induced VEP, its amplitude increases with peak irradiance and pulse duration, and decreases with frequency in the range of 2–20 Hz, similar to the visible light response. Modular design of the arrays allows scalability to a large number of pixels, and combined with the ease of implantation, offers a promising approach to restoration of sight in patients blinded by retinal degenerative diseases.

Related Stories

Eye implants make vision-restoring progress

July 18, 2012
(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as evidenced by Second ...

Solar-panel-like retinal prosthesis could better restore sight to blind

May 13, 2012
(Phys.org) -- Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost ...

Retinal implants with wireless microchip restore functional vision in retinitis pigmentosa patients, research finds

February 20, 2013
(Medical Xpress)—Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), announced results from part of its multicentre study were published today in the peer-reviewed ...

Recommended for you

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Reproducing a retinal disease on a chip

June 15, 2017
Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017
In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.